Gerard M Turino Selected Research

Pulmonary Emphysema

1/2021	A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
1/2018	Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy.
1/2016	Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
8/2013	Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
5/2005	Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema.
1/2004	Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema?
2/2002	The effect of lysozyme on elastase-mediated injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard M Turino Research Topics

Disease

16	Chronic Obstructive Pulmonary Disease (COPD) 07/2022 - 10/2003
7	Pulmonary Emphysema 01/2021 - 02/2002
4	Emphysema 01/2018 - 02/2002
3	Disease Progression 01/2020 - 01/2018
3	Lung Diseases (Lung Disease) 01/2019 - 01/2006
3	Asthma (Bronchial Asthma) 10/2011 - 03/2003
2	Inflammation (Inflammations) 01/2019 - 07/2012
1	Liver Diseases (Liver Disease) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 04/2019
1	Cachexia 01/2019
1	Pulmonary Arterial Hypertension 07/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011
1	Bronchitis 10/2011
1	Hypertension (High Blood Pressure) 04/2009
1	Hypercholesterolemia 04/2009
1	Lung Injury 01/2006
1	Hyperoxia 01/2006
1	Respiratory Sounds (Crackle) 03/2003
1	Hypersensitivity (Allergy) 03/2003

Drug/Important Bio-Agent (IBA)

13	ElastinIBA 07/2022 - 05/2007
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
6	DesmosineIBA 01/2021 - 05/2007
6	IsodesmosineIBA 01/2021 - 05/2007
5	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2004
5	Pancreatic Elastase (Elastase)IBA 01/2018 - 02/2002
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2013
3	Bronchodilator Agents (Bronchodilators)IBA 04/2009 - 03/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
2	AerosolsIBA 01/2018 - 01/2018
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2018 - 01/2016
2	SmokeIBA 10/2011 - 05/2005
2	Peptides (Polypeptides)IBA 11/2010 - 10/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Janus KinasesIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Fibrinogen (Factor I)FDA Link 01/2016
1	C-Reactive ProteinIBA 07/2012
1	Tobacco Smoke Pollution (Passive Smoking)IBA 10/2011
1	Amino Acids FDA Link 10/2011
1	IonsIBA 11/2010
1	Peptide FragmentsIBA 11/2010
1	valyl-glycyl-valyl-alanyl-prolyl-glycineIBA 11/2010
1	Antihypertensive Agents (Antihypertensives)IBA 04/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2009
1	Tiotropium Bromide (Spiriva)FDA Link 02/2009
1	thiamine triphosphorate (TTP)IBA 02/2009
1	Oxidants (Oxidizing Agents)IBA 01/2006
1	Immunoglobulin E (IgE)IBA 03/2003
1	Muramidase (Lysozyme)IBA 02/2002

Therapy/Procedure

9	Therapeutics 01/2020 - 03/2003